nach oben

Journal of Endocrinological Investigation

Erschienen in:

01.02.2020 | Original Article

Whole exome sequencing in familial isolated primary hyperparathyroidism

verfasst von: F. Cetani, E. Pardi, P. Aretini, F. Saponaro, S. Borsari, L. Mazoni, M. Apicella, P. Civita, M. La Ferla, M. A. Caligo, F. Lessi, C. M. Mazzanti, L. Torregossa, A. Oppo, C. Marcocci

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Familial isolated hyperparathyroidism (FIHP) is a rare inherited disease accounting for 1% of all cases of primary hyperparathyroidism (PHPT). It is genetically heterogeneous being associated with mutations in different genes, including MEN1, CDC73, CASR, and recently GCM2. The aim of the study was to further investigate the molecular pathogenesis in Italian FIHP kindreds.

Methods

We used whole exome sequencing (WES) in the probands of seven unrelated FIHP kindreds. We carried out a separate family-based exome analysis in a large family characterized by the co-occurrence of PHPT with multiple tumors apparently unrelated to the disease. Selected variants were also screened in 18 additional FIHP kindreds. The clinical, biochemical, and pathological characteristics of the families were also investigated.

Results

Three different variants in GCM2 gene were found in two families, but only one (p.Tyr394Ser), already been shown to be pathogenic in vitro, segregated with the disease. Six probands carried seven heterozygous missense mutations segregating with the disease in the FAT3, PARK2, HDAC4, ITPR2 and TBCE genes. A genetic variant in the APC gene co-segregating with PHPT (p.Val530Ala) was detected in a family whose affected relatives had additional tumors, including colonic polyposis.

Conclusion

We confirm the role of GCM2 germline mutations in the pathogenesis of FIHP, although at a lower rate than in the previous WES study. Further studies are needed to establish the prevalence and the role in the predisposition to FIHP of the novel variants in additional genes.

Nur mit Berechtigung zugänglich

Brewer K, Costa-Guda J, Arnold A (2019) Molecular genetic insights into sporadic primary hyperparathyroidism. Endocr Relat Cancer 26:R53–R72. https://doi.org/10.1530/ERC-18-0304 CrossRefPubMed

Cardoso L, Stevenson M, Thakker RV (2017) Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma. Hum Mutat 38:1621–1648. https://doi.org/10.1002/humu.23337 CrossRefPubMedPubMedCentral

Marx SJ (2019) New concepts about familial isolated hyperparathyroidism. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2018-02789 CrossRefPubMedPubMedCentral

Pontikides N, Karras S, Kaprara A et al (2014) Genetic basis of familial isolated hyperparathyroidism: a case series and a narrative review of the literature. J Bone Miner Metab 32:351–366. https://doi.org/10.1007/s00774-013-0551-9 CrossRefPubMed

Pardi E, Borsari S, Saponaro F et al (2017) Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features. PLoS One 12:1–22. https://doi.org/10.1371/journal.pone.0186485 CrossRef

Guan B, Welch JM, Sapp JC et al (2016) GCM2-activating mutations in familial isolated hyperparathyroidism. Am J Hum Genet 99:1034–1044. https://doi.org/10.1016/j.ajhg.2016.08.018 CrossRefPubMedPubMedCentral

Günther T, Chen Z-F, Kim J et al (2000) Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature 406:199–203. https://doi.org/10.1038/35018111 CrossRefPubMed

Guan B, Welch JM, Vemulapalli M et al (2017) Ethnicity of patients with germline GCM2 -activating variants and primary hyperparathyroidism. J Endocr Soc 1:488–499. https://doi.org/10.1210/js.2017-00043 CrossRefPubMedPubMedCentral

Cetani F, Pardi E, Giovannetti A et al (2002) Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism. Clin Endocrinol (Oxf) 56:457–464. https://doi.org/10.1046/j.1365-2265.2002.01502.x CrossRef

10.

Guo Y, Ding X, Shen Y et al (2015) SeqMule: automated pipeline for analysis of human exome/genome sequencing data. Sci Rep 5:1–10. https://doi.org/10.1038/srep14283 CrossRef

11.

Quang D, Chen Y, Xie X (2015) DANN: a deep learning approach for annotating the pathogenicity of genetic variants. Bioinformatics 31:761–763. https://doi.org/10.1093/bioinformatics/btu703 CrossRefPubMed

12.

Kopanos C, Tsiolkas V, Kouris A et al (2019) VarSome: the human genomic variant search engine. Bioinformatics 35:1978–1980. https://doi.org/10.1093/bioinformatics/bty897 CrossRefPubMed

13.

Rouillard AD, Gundersen GW, Fernandez NF et al (2016) The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database 2016:1–16. https://doi.org/10.1093/database/baw100 CrossRef

14.

Pandya C, Uzilov AV, Bellizzi J et al (2017) Genomic profiling reveals mutational landscape in parathyroid carcinomas. Jci Insight 2:1–14. https://doi.org/10.1172/jci.insight.92061 CrossRef

15.

Okur V, Chung WK (2017) The impact of hereditary cancer gene panels on clinical care and lessons learned. Mol Case Stud 3:1–15. https://doi.org/10.1101/mcs.a002154 CrossRef

16.

Ponz de Leon M, Urso E, Pucciarelli S et al (2013) Clinical and molecular features of attenuated adenomatous polyposis in northern Italy. Tech Coloproctol 17:79–87. https://doi.org/10.1007/s10151-012-0887-5 CrossRefPubMed

17.

Ding C, Buckingham B, Levine MA et al (2001) Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB. J Clin Invest 108:1215–1220. https://doi.org/10.1172/JCI200113180.Introduction CrossRefPubMedPubMedCentral

18.

Riccardi A, Aspir T, Shen L et al (2019) Analysis of activating GCM2 sequence variants in sporadic parathyroid adenomas. J Clin Endocrinol Metab 104:1948–1952. https://doi.org/10.1210/jc.2018-02517 CrossRefPubMed

19.

El Lakis M, Nockel P, Guan B et al (2018) Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure. Surgery 163:31–34. https://doi.org/10.1016/j.surg.2017.04.027 CrossRef

20.

Maret A, Ding C, Kornfield SL, Levine MA (2018) Analysis of the GCM2 gene in isolated hypoparathyroidism: a molecular and biochemical study. J Clin Endocrinol Metab 93:1426–1432. https://doi.org/10.1210/jc.2007-1783 CrossRef

21.

Parvari R, Diaz A, Hershkovitz E (2007) Parathyroid development and the role of tubulin chaperone e. Horm Res 67:12–21. https://doi.org/10.1159/000095944 CrossRefPubMed

22.

Fiala O, Zahorakova D, Pospisilova L et al (2014) Parkin (PARK 2) mutations are rare in czech patients with early-onset parkinson’ s disease. PLOS One 9:1–6. https://doi.org/10.1371/journal.pone.0107585 CrossRef

23.

Xiong D, Wang Y, Kupert E et al (2015) A recurrent mutation in PARK2 is associated with familial lung cancer. Am J Hum Genet 96:301–308. https://doi.org/10.1016/j.ajhg.2014.12.016 CrossRefPubMedPubMedCentral

24.

Hu H, Kannengiesser C, Lesage S et al (2016) PARKIN inactivation links parkinson’ s disease to melanoma. JNCI J Natl Cancer Inst 108:1–8. https://doi.org/10.1093/jnci/djv340 CrossRef

25.

Kasten M, Hartmann C, Hampf J et al (2018) Genotype-phenotype relations for the parkinson’ s disease genes parkin, PINK1, DJ1: MDSGene systematic review. Mov Disord 33:730–741. https://doi.org/10.1002/mds.27352 CrossRefPubMed

26.

Gong Y, Zack T, Morris L et al (2014) Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins Yongxing. Nat Genet 46:588–594. https://doi.org/10.1038/ng.2981.Pan-cancer CrossRefPubMedPubMedCentral

27.

Bartek J, Hodn Z (2014) PARK2 orchestrates cyclins to avoid cancer. Nat Genet 46:527–528. https://doi.org/10.1038/ng.2992 CrossRefPubMed

28.

Arnold A (2016) Major molecular genetic drivers in sporadic primary hyperparathyroidism. Trans Am Clin Climatol Assoc 127:235–244PubMedPubMedCentral

29.

Poulogiannis G, Mcintyre RE, Dimitriadi M et al (2010) PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice. Proc Natl Acad Sci 107:15145–15150. https://doi.org/10.1073/pnas.1009941107 CrossRefPubMed

30.

Ameratunga R, Woon ST, Bryant VL et al (2018) Clinical implications of digenic inheritance and epistasis in primary immunodeficiency disorders. Front Immunol 8:1–8. https://doi.org/10.3389/fimmu.2017.01965 CrossRef

31.

Parra M (2015) Class IIa HDACs—new insights into their functions in physiology and pathology. FEBS J 282:1736–1744. https://doi.org/10.1111/febs.13061 CrossRefPubMed

32.

Di Giorgio E, Clocchiatti A, Piccinin S et al (2013) MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/Akt-induced transformation. Mol Cell Biol 33:4473–4491. https://doi.org/10.1128/MCB.01050-13 CrossRef

33.

Wiel C, Lallet-Daher H, Gitenay D et al (2014) Endoplasmic reticulum calcium release through ITPR2 channels leads to mitochondrial calcium accumulation and senescence. Nat Commun 5:3792. https://doi.org/10.1038/ncomms4792 CrossRefPubMed

34.

Aretz S, Vasen HFA, Olschwang S (2014) Clinical utility gene card for: familial adenomatous polyposis (FAP) and attenuated FAP (AFAP)—update 2014. Eur J Hum Genet 23:1–4. https://doi.org/10.1038/ejhg.2014.193 CrossRef

35.

Kerr SE, Thomas CB, Thibodeau SN et al (2013) APC germline mutations in individuals being evaluated for familial adenomatous polyposis a review of the mayo clinic experience with 1591 consecutive tests. J Mol Diagnostics 15:31–43. https://doi.org/10.1016/j.jmoldx.2012.07.005 CrossRef

36.

Breitman M, Zilberberg A, Caspi M, Rosin-arbesfeld R (2008) The armadillo repeat domain of the APC tumor suppressor protein interacts with striatin family members. Biochim Biophys Acta 1783:1792–1802. https://doi.org/10.1016/j.bbamcr.2008.04.017 CrossRefPubMed

37.

Crist RC, Roth JJ, Baran AA et al (2010) The armadillo repeat domain of Apc suppresses intestinal tumorigenesis. Mamm Genome 21:450–457. https://doi.org/10.1007/s00335-010-9288-0 CrossRefPubMedPubMedCentral

38.

Sakai Y, Koizumi K, Sugitani I et al (2002) Familial adenomatous polyposis associated with multiple endocrine neoplasia type 1-related tumors and thyroid carcinoma. Am J Surg Pathol 26:103–110CrossRef

39.

Uchino S, Ishikawa H, Miyauchi A et al (2016) Age- and gender-specific risk of thyroid cancer in patients with familial adenomatous polyposis. J Clin Endocrinol Metab 101:4611–4617. https://doi.org/10.1210/jc.2016-2043 CrossRefPubMed

40.

Resta N, Stella A, Susca F et al (2001) Nine novel APC mutations in Italian FAP patients. Hum Mutat 415:1–5

41.

Scott R, Taeschner W, Heinimann K et al (1997) Association of extracolonic manifestations of familial adenomatous polyposis with acetylation phenotype in a large FAP kindred. Eur J Hum Genet 5:43–49CrossRef

42.

Soravia C, Sugg SL, Berk T et al (1999) Familial adenomatous polyposis-associated thyroid cancer a clinical, pathological, and molecular genetics study. Am J Pathol 154:127–135CrossRef

43.

Mali P, Muduganti S, Enwezor C (2014) Rare case of non-Hodgkin’s lymphoma in a patient with multiple hyperplastic colon polyps. Case Rep Intern Med 2:83–85. https://doi.org/10.5430/crim.v2n1p83 CrossRef

44.

Svedlund J, Aurén M, Sundström M et al (2010) Aberrant WNT/b -catenin signaling in parathyroid carcinoma. Mol Cancer 9:294. https://doi.org/10.1186/1476-4598-9-294 CrossRefPubMedPubMedCentral

45.

Kasaian K, Wiseman SM, Thiessen N et al (2013) Complete genomic landscape of a recurring sporadic parathyroid carcinoma. J Pathol 230:249–260. https://doi.org/10.1002/path.4203 CrossRefPubMed

46.

Clarke CN, Katsonis P, Hsu T et al (2018) Comprehensive genomic characterization of parathyroid cancer identifies novel candidate driver mutations & core pathways. J Endocr Soc. https://doi.org/10.1210/js.2018-00043 CrossRefPubMedPubMedCentral

47.

Cui M, Hu Y, Bi Y et al (2019) Preliminary exploration of potential molecular therapeutic targets in recurrent and metastatic parathyroid carcinomas. Int J Cancer 144:525–532. https://doi.org/10.1002/ijc.31948 CrossRefPubMed

48.

Talseth-Palmer BA (2017) The genetic basis of colonic adenomatous polyposis syndromes. Hered Cancer Clin Pract 15:1–7. https://doi.org/10.1186/s13053-017-0065-x CrossRef

49.

Cetta F (2015) FAP associated papillary thyroid carcinoma: a peculiar subtype of familial nonmedullary thyroid cancer. Patholog Res Int. https://doi.org/10.1155/2015/309348 CrossRefPubMedPubMedCentral

50.

Groen RWJ, Oud MECM, Schilder-Tol EJM et al (2008) Illegitimate WNT pathway activation by β-catenin mutation or autocrine stimulation in T-cell malignancies. Cancer Res 68:6969–6977. https://doi.org/10.1158/0008-5472.CAN-08-1322 CrossRefPubMed

51.

Deltas C (2018) Digenic inheritance and genetic modifiers. Clin Genet 93:429–438. https://doi.org/10.1111/cge.13150 CrossRefPubMed

Titel: Whole exome sequencing in familial isolated primary hyperparathyroidism
verfasst von: F. Cetani
E. Pardi
P. Aretini
F. Saponaro
S. Borsari
L. Mazoni
M. Apicella
P. Civita
M. La Ferla
M. A. Caligo
F. Lessi
C. M. Mazzanti
L. Torregossa
A. Oppo
C. Marcocci
Publikationsdatum: 01.02.2020
Verlag: Springer International Publishing
Erschienen in: Journal of Endocrinological Investigation / Ausgabe 2/2020
Elektronische ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-019-01107-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Eingreifen von Umstehenden rettet vor Erstickungstod!

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2020

Could Amedeo Modigliani have painted a thyroid swelling?

A broad range of symptoms in allgrove syndrome: single center experience in Southeast Anatolia

Exon 3-deleted growth hormone receptor isoform is not related to worse bone mineral density or microarchitecture or to increased fracture risk in acromegaly

Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis

A complete flaccid quadriparesis as early presentation of Graves’ disease